Skip to main content

A High-Throughput Flow Cytometry Assay for Identification of Inhibitors of 3′,5′-Cyclic Adenosine Monophosphate Efflux

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1439))

Abstract

Assays to identify small molecule inhibitors of cell transporters have long been used to develop potential therapies for reversing drug resistance in cancer cells. In flow cytometry, these approaches rely on the use of fluorescent substrates of transporters. Compounds which prevent the loss of cell fluorescence have typically been pursued as inhibitors of specific transporters, but further drug development has been largely unsuccessful. One possible reason for this low success rate could be a substantial overlap in substrate specificities and functions between transporters of different families. Additionally, the fluorescent substrates are often synthetic dyes that exhibit promiscuity among transporters as well. Here, we describe an assay in which a fluorescent analog of a natural metabolite, 3′,5′-cyclic adenosine monophosphate (F-cAMP), is actively effluxed by malignant leukemia cells. The F-cAMP is loaded into the cell cytoplasm using a procedure based on the osmotic lysis of pinocytic vesicles. The flow cytometric analysis of the fluorescence retained in F-cAMP-loaded cells incubated with various compounds can subsequently identify inhibitors of cyclic AMP efflux (ICE).

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Fletcher JI, Haber M, Henderson MJ, Norris MD (2010) ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer 10(2):147–156

    Article  CAS  Google Scholar 

  2. Zinzi L et al (2014) ABC transporters in CSCs membranes as a novel target for treating tumor relapse. Front Pharmacol 5:163

    Article  Google Scholar 

  3. Aronsen L, Orvoll E, Lysaa R, Ravna AW, Sager G (2014) Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors. Eur J Pharmacol 745:249–253

    Article  CAS  Google Scholar 

  4. Wu C-P, Calcagno AM, Ambudkar SV (2008) Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr Mol Pharmacol 1(2):93–105

    Article  CAS  Google Scholar 

  5. Shiozawa K et al (2004) Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic. Int J Cancer 108(1):146–151

    Article  CAS  Google Scholar 

  6. Jekerle V et al (2006) In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques. Int J Cancer 119(2):414–422

    Article  CAS  Google Scholar 

  7. Ozben T (2006) Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett 580(12):2903–2909

    Article  CAS  Google Scholar 

  8. Zarrin A, Mehdipour AR, Miri R (2010) Dihydropyridines and multidrug resistance: previous attempts, present state, and future trends. Chem Biol Drug Des 76(5):369–381

    Article  CAS  Google Scholar 

  9. Nigam SK (2014) What do drug transporters really do? Nat Rev Drug Discov 14(1):29–44

    Article  Google Scholar 

  10. Copsel S et al (2011) Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation. J Biol Chem 286(9):6979–6988

    Article  CAS  Google Scholar 

  11. Fajardo AM, Piazza GA, Tinsley HN (2014) The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment. Cancers (Basel) 6(1):436–458

    Article  Google Scholar 

  12. Coffino P, Bourne HR, Tomkins GM (1975) Mechanism of lymphoma cell death induced by cyclic AMP. Am J Pathol 81:199–204

    CAS  Google Scholar 

  13. Dou A, Wang X (2010) Cyclic adenosine monophosphate signal pathway in targeted therapy of lymphoma. Chin Med J (Engl) 123(1):95–99

    CAS  Google Scholar 

  14. Zhang J, Chung T, Oldenburg K (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2):67–73

    Article  Google Scholar 

Download references

Acknowledgments

This work was supported by The Oxnard Foundation, University of New Mexico Clinical & Translational Science Center Pilot Award 1UL1RR031977, and New Mexico Cancer Nanotechnology Training Center grant R25CA153825.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Larry A. Sklar .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Perez, D., Simons, P.C., Smagley, Y., Sklar, L.A., Chigaev, A. (2016). A High-Throughput Flow Cytometry Assay for Identification of Inhibitors of 3′,5′-Cyclic Adenosine Monophosphate Efflux. In: Janzen, W. (eds) High Throughput Screening. Methods in Molecular Biology, vol 1439. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3673-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3673-1_15

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-3671-7

  • Online ISBN: 978-1-4939-3673-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics